SMR › analyze
SMR · Analyze
A portfolio-specific passage was removed from the public build.
0. Knowledge check
kb.py find SMR returned one hit: Knowledge/Themes/nuclear-uranium.md (swept 2026-06-10,
refined 2026-07-31) — its governing point is that "nuclear exposure" spans risk types by fuel-cycle
layer, and SMR sits in the speculative, pre-revenue layer alongside OKLO, distinct from
generation (CEG/VST, contracted cash flow) and mining. kb.py find NuScale returned no matches.
Watchlist.md carries a detailed prior decision note (2026-08-10, not a full report) sizing the
position for total loss — its headline numbers are re-verified below and one of them is corrected
(see §1, FCF).
Two live pitfalls fired directly on this pull:
- pitfall-yahoo-snapshot-fcf-field-diverges-from-quarter-sum / pitfall-single-quarter-fcf-read-as-ttm
— SMR's get_stock_info freeCashflow field (−$204.6M) is not TTM. It reproduces Q4 2025's
own quarterly FCF (−$204.07M) almost to the dollar. True TTM FCF is −$778.8M, reconciled two
independent ways below. This also corrects the Watchlist note's "FCF −$205M," which was the same
single-quarter figure.
- pitfall-yahoo-insider-purchases-counts-rsu-grants — not queried via the summary field; read
insider_transactions rows directly per the pitfall's instruction. Confirmed below: zero
open-market purchases in the trailing 12 months.
1. Fundamentals — cash, burn, dilution
TTM revenue: $10.69M, and collapsing sequentially, not just "pre-revenue."
| Quarter | Revenue |
|---|---|
| Q3 2025 | $8.24M |
| Q4 2025 | $1.81M |
| Q1 2026 | $0.57M |
| Q2 2026 | $0.075M |
| TTM | $10.69M (−99% YoY per vendor field) |
This is engineering/design-services revenue (RoPower FEED work, DOE cost-share) running off, not a company scaling toward product revenue. First commercial NPM revenue is not expected before ~2030–2033 on any disclosed timeline.
TTM free cash flow, reconciled from quarterly statements (never the snapshot aggregate):
| Quarter | OCF | Capex | FCF |
|---|---|---|---|
| Q3 2025 | −$199.80M | −$0.14M | −$199.94M |
| Q4 2025 | −$203.70M | −$0.37M | −$204.07M |
| Q1 2026 | −$314.68M | −$1.52M | −$316.20M |
| Q2 2026 | −$58.18M | −$0.43M | −$58.61M |
| TTM | −$776.36M | −$2.46M | −$778.82M |
Two independent checks agree to the dollar (OCF−capex, and the sum of each quarter's own
pre-computed FCF cell). The vendor's operatingCashflow snapshot field also matches the TTM sum
exactly (−$776,363,008) — only the freeCashflow field is broken, and it is broken in the
single-quarter direction.
The TTM burn is inflated by a one-time event, not a steady run-rate. Q3 2025 G&A spiked to $519.2M (from ~$22-45M in adjacent quarters) on a $495M non-cash "Milestone Contribution 1" accrued to ENTRA1 Energy under NuScale's Partnership Milestones Agreement, triggered when ENTRA1 signed its non-binding TVA agreement covering 72 NPMs. That charge hit the P&L in Q3 2025 as an accrued payable (not cash), then was paid down in cash across Q4 2025 (−$116M) and Q1 2026 (−$265M) — which is why Q1 2026's FCF (−$316.2M) is so much worse than the adjacent quarters. By Q2 2026 the payable was largely worked down and quarterly FCF normalized to −$58.6M (~$234M annualized) — a more representative core run-rate.
Two burn rates, both matter: - Reported TTM: −$778.8M (contaminated by the one-time ENTRA1 catch-up) - Core run-rate (latest clean quarter, annualized): ~$230-250M/yr
🚩 The ENTRA1 Partnership Milestones Agreement is a forward liability, not a closed event. "Milestone Contribution 1" implies further milestones exist as deals progress from non-binding to binding. The size and trigger conditions for Milestone 2+ were not confirmed in this pass (10-Q note review needed at the next filing) — this is a material open question for anyone modeling runway, because another milestone of comparable size would materially shorten it.
Cash position (Q2 2026, most recent quarter): $1.072B cash + short-term investments ($766.5M cash, $305.7M STI). Debt is negligible — $756K, entirely a capital lease. D/E and Debt/Assets are not meaningful risk flags here; balance-sheet risk is dilution risk, not leverage risk.
Runway: $1.07B ÷ core run-rate ($230-250M/yr) ≈ 4.3-4.6 years if spend stays near the Q2 2026 pace and no further large milestone contribution lands. $1.07B ÷ the full TTM figure ($778.8M) ≈ 1.4 years — the pessimistic read if another ENTRA1-scale payment recurs. The honest range is 1.5-4.5 years, and which end it lands on depends entirely on the ENTRA1 milestone schedule, which is not fully disclosed in the data pulled.
🚩 Dilution is severe and accelerating, not decelerating.
| Period | Shares outstanding |
|---|---|
| FY2022 | 69.35M |
| FY2023 | 76.90M |
| FY2024 | 122.84M |
| Q3 2025 | 167.60M |
| Q4 2025 | 318.48M |
| Q1 2026 | 323.74M |
| Q2 2026 | 410.39M |
Share count is up 5.9x since 2022 and +145% in the three quarters from Q3 2025 to Q2 2026 alone — the pace is accelerating, not tapering, as the company funds its cash pile and its ENTRA1 obligations with continuous ATM-style equity issuance ($462.6M in Q3 2025, $737.4M in Q4 2025, $947.2M in Q2 2026 — $2.15B raised via equity in three quarters). GAAP diluted EPS widened from −$0.51 (2022) to −$2.17 (2025 annual, −$2.20 TTM) despite the share count nearly quintupling — total losses are growing faster than dilution can spread them. The cash cushion funding the runway estimate above is the same mechanism destroying per-share value.
Capital allocation: ~100% of cash raised goes to (a) operating burn, (b) the ENTRA1 milestone obligation, and (c) minimal capex ($2.46M TTM — there is essentially no physical construction spend yet, consistent with pre-EPC status on every disclosed project). No buybacks, no dividend, no M&A. This is a pure cash-preservation-and-optionality-funding posture, appropriate for the stage but worth naming plainly.
2. Order book & regulatory status (the thesis, not the balance sheet)
- NRC design certification — the one durable asset. NuScale's uprated 77 MWe / US460 design received NRC Standard Design Approval in May 2025, the only SMR design with US regulatory approval at this scale. This took ~15 years and hundreds of millions of dollars and is a real, hard-to-replicate barrier — the strongest evidence of a moat-in-the-making.
- RoPower / Romania (Doicești, 6 NPMs). Nuclearelectrica shareholders approved a Final Investment Decision in February 2026, moving the project from "analysis" into implementation. As of Q2 2026, NuScale/RoPower are still working through pre-EPC conditions — geotechnical work, licensing, long-lead procurement. No signed EPC contract yet. Management's own target is operational status "at the beginning of the next decade" (~2030-2031+), and that is explicitly contingent on further approvals.
- TVA / ENTRA1 (up to 6-8 GW, the headline catalyst). Still non-binding. ENTRA1 signed a non-binding agreement with TVA covering 72 NPMs (Sept 2025); management's public target is a signed power purchase agreement (PPA) by end of 2026. Under the deal structure, ENTRA1 — not NuScale — would finance and own the plants and sell output to TVA; NuScale supplies the technology and, per the milestone agreement above, gets paid milestone contributions to ENTRA1 in the other direction as the deal advances (an unusual structure worth sitting with: NuScale pays its own commercialization partner as the partner's deals progress).
- No firm, binding order for a US utility deployment exists yet. Everything disclosed is non-binding MOUs, an FID-approved-but-pre-EPC Romanian project, and milestone-linked payments to a partner whose own qualifications are the subject of active litigation (below).
3. Sentiment & governance — front-and-center
🚩 Securities fraud class action, open. Truedson v. NuScale Power Corp., D. Or., covering purchasers between 2025-05-13 and 2025-11-06. The core allegation: ENTRA1 Energy — NuScale's exclusive global commercialization partner, the counterparty in the $495M milestone payment above — lacked meaningful prior experience building, financing, or operating nuclear projects, and that qualifications attributed to ENTRA1 actually belonged to a different entity (the Habboush Group). The trigger event was the Q3 2025 G&A disclosure itself — the stock fell ~14.4% on the news. This is not resolved; it is a live legal and reputational risk sitting directly on top of the company's single most important commercial relationship.
🚩 Fluor Corp — the founding EPC partner and largest insider — has been steadily and almost completely exiting. Fluor sold in tranches nearly every month from August 2025 through April 2026, across a falling price band from the mid-$40s down to $9.30, including blocks of 13.5M, 15M, 71M(-equivalent cumulative), and 12.9M shares. This is a strategic partner liquidating its stake through the entire decline, not adding on weakness.
No open-market insider buying anywhere in the trailing 12 months. Every Form 4 "purchase"-side
row is either a $0.00 RSU/stock-award grant or a legacy-strike option conversion ($3.20-$3.41)
immediately followed by a sale — confirmed by reading insider_transactions directly per
pitfall-yahoo-insider-purchases-counts-rsu-grants. CEO, CFO, COO, and CTO have all sold routinely
on every vest since 2025. This is a golden-flag absence, not neutral — insiders are cashing
out consistently, including the CFO converting-and-selling as recently as August 17-18, 2026.
Analyst coverage is split and has been cutting targets across the board. 15 analysts, consensus "Hold" (2.56/5). Mean target $12.63, median $11, range $6-$20 — the entire range has compressed downward over 2026: Cantor cut $55→$20 (Feb), Goldman $20→$14 (Mar), UBS $20→$13 (Mar), Barclays $15→$11 (Jul), Canaccord $25→$15 (Aug), RBC $14→$10 (Aug), Citi reiterated Sell, cutting $7.50→$6.50 (Aug). Every single revision in 2026 has been a cut, regardless of the underlying rating — this is a sell-side repricing the pace of the thesis (deals still non-binding) even where the rating itself (Buy at Canaccord/B.Riley/Cantor) survives.
Recent news is mixed noise, not signal. An AI-tooling partnership (Nuclearn/NPX, "80% information-retrieval speedup") drove a bounce and a reversal within 48 hours (+higher premarket on 8/26 news, then −7% same day, +4% on 8/27) — this is optionality-repricing volatility around a minor operational announcement, not new order-book information. The Motley Fool "TVA deal could be the biggest nuclear contract in US history" pieces describe the same still-non-binding agreement covered above.
4. Moat — is there one yet?
Partial, and licensing-shaped, not commercial. The NRC Standard Design Approval is real and durable — a genuine regulatory moat that took over a decade and is not easily replicated. But it has not yet converted into a single binding revenue-generating contract, and well-funded competitors are closing the gap from different angles: GE-Hitachi's BWRX-300 already has utility commitments and construction activity underway (TVA Clinch River, Ontario Power Generation) despite lacking NuScale's head start on NRC approval — arguably ahead on execution even though behind on certification. OKLO, Kairos Power, X-energy, Rolls-Royce SMR, and multiple hyperscaler-backed efforts are all racing the same AI-power-demand tailwind. Adversarial test: a rival with a comparable or faster-to-market design and a committed anchor customer could win the "first firm US deployment" narrative before NuScale converts TVA or RoPower to binding — at which point NuScale's certification lead becomes a historical footnote rather than a durable edge. The moat is real but time-limited and unconverted; it is an option on being first, not yet a business.
5. Valuation — binary, framed on cash and optionality, not earnings
Graham IV, P/E, FCF-multiple, and DDM/DYT are all N/A — no earnings, no meaningful FCF sign, no dividend. The only honest valuation framing here is what the market is paying for the option:
- Market cap: $4.00B · Cash + ST investments: $1.07B · EV: $2.69B
- Cash per share: ~$2.61 (410.4M shares) vs. price $9.74 — ~73% of the current price is pure option value on deal conversion; ~27% is covered by liquid, mostly-cash book value.
- Book value is now almost entirely cash-backed (total assets $2.05B, of which $1.07B is cash/STI, against only $8.3M of goodwill and $17.3M of other intangibles) — so P/B of 2.65x is a direct read on how much premium the market is paying over a mostly-cash balance sheet for the NRC-certified design plus the TVA/RoPower optionality.
Two branches, not a point estimate:
- Failure branch (order book stays non-binding, ENTRA1/litigation overhang persists, dilution continues at pace): the $2.69B EV of pure optionality re-rates toward zero over 2-4 years while cash floor (~$2.50-3/share, falling as burn continues and further shares are issued) provides a soft bottom well below today's $9.74. This is consistent with where sell-side price targets have been drifting all year (every 2026 revision has been a cut).
- Optionality branch (TVA PPA signs in 2026 as management targets, and/or RoPower reaches a binding EPC contract): the de-risking event re-rates the multiple toward or above the 200-day average ($13.57), potentially back toward where analyst targets cluster ($11-15). This is a re-rating on reduced uncertainty, not on near-term earnings — first real project revenue is still ~2030+ on every disclosed timeline, so even the bull case is a multi-year story.
No fair-value point estimate is offered — that would fake precision on a name where the outcome is genuinely bimodal and outside the company's own control (a counterparty's financing decision, an NRC-adjacent regulatory process, an ongoing lawsuit).
6. Synthesis & verdict
Tensions, named plainly: - Sentiment (Fluor's near-total exit, zero insider buying, an open securities-fraud suit tied directly to the ENTRA1 relationship) is unambiguously bearish on management/governance quality. - The regulatory/technical asset (sole NRC-approved SMR design) is a real, positive, durable fact that the sentiment picture does not erase — it is why this is "binary optionality," not "worthless." - Fundamentals confirm the position is being kept alive by continuous, accelerating dilution, not operating traction — revenue is going to zero, not building from it.
Weighting: for a pre-revenue, binary-outcome name, sentiment and the order-book status outweigh anything balance-sheet-shaped — the cash pile is a means of buying time for an outcome that is decided by counterparties (TVA, Nuclearelectrica) and a court, not by NuScale's own execution. On that basis this stays a decided, small, total-loss-sized position rather than a name to size up on the strength of "$1B+ in the bank."
Verdict: HOLD (decided position, do not add), conviction 2.0 — unchanged from the prior Watchlist decision, net of new findings that roughly offset. New bearish evidence this pass: revenue has collapsed to $75K/quarter (not just "small"), Fluor's exit is now visibly near-total across the full price decline, and the ENTRA1 milestone structure is a real forward liability with undisclosed future tranches. New context that tempers rather than reverses that: the reported "$778.8M TTM burn" is substantially a one-time ENTRA1 catch-up rather than a steady-state rate — the core run-rate (~$230-250M/yr) gives a more survivable 4+-year runway than the headline number implies, provided no further milestone-scale payment lands. Net: the position is exactly as risky as previously assessed, for adjusted reasons. Do not add. Do not average down. The existing ~$97 stake (10 sh, ~0.3% of the Self account) remains appropriately sized for a binary bet already accepted as a possible total loss.
Entry: avoid for new capital at any price under current conditions — there is no valuation discipline that applies to a name with no revenue and no binding contracts; entry here is a bet on catalysts, not a price level.
Trim: n/a — not a price-based trim candidate. The only two things that should change this position's size: (1) a firm order converts from MOU/non-binding to a signed, binding contract with real financing (upgrade trigger), or (2) the TVA agreement is abandoned, the class action produces an adverse finding tied to ENTRA1's qualifications, or another ENTRA1-scale milestone payment lands without a matching binding-deal conversion (exit-review trigger).
Key risks (front and center, for the record)
- Revenue is at $75K/quarter and falling — not a growth story on any near-term view.
- Dilution is accelerating: +145% share count in three quarters; core losses per share widening despite the larger share count.
- Open securities-fraud litigation tied directly to the qualifications of NuScale's exclusive commercialization partner (ENTRA1/Habboush allegations).
- Fluor, the founding strategic/EPC partner, has sold down to near-nothing across the entire price decline — a genuine golden-flag absence, not neutral.
- The ENTRA1 Partnership Milestones Agreement is an undisclosed-size forward liability — "Milestone Contribution 1" ($495M) implies further tranches as deals progress; size/triggers for Milestone 2+ were not confirmed in this pass and materially affect the runway range (1.5-4.5 yrs).
- Zero binding US deployment contract exists — TVA is non-binding; RoPower is FID-approved but pre-EPC; first plausible commercial revenue is not before ~2030.
- Zero open-market insider buying across the entire drawdown.
Golden flags (for balance)
- Sole NRC Standard Design Approval among SMR developers (US460, 77 MWe, approved May 2025) — a genuine, hard-to-replicate regulatory asset.
- $1.07B cash, effectively no debt — the company controls its own runway timeline for now.
- RoPower Romania cleared FID in February 2026 — real, if slow, progress on the one project with an actual investment decision behind it.
- Current price ($9.74) sits well below both the median ($11) and mean ($12.63) analyst target, and near the low end of the 52-week range ($7.21-$57.42) — asymmetry exists if a binding deal lands, though the repeated 2026 target cuts show the sell-side has been wrong about timing all year.
A portfolio-specific passage was removed from the public build.